BI

Healthcare · Pharmaceuticals

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

₹29.37

Mkt cap
₹48 Cr
P/E ratio
91.90
P/B
2.19
Div yield
0.00%
ROE
−2.83%
ROCE
2.97%
EPS (TTM)
₹0.32
Book value
₹13
52W range
26–46
Sector
Healthcare

Price history

Previous close

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products. [1]

NSE BIOFILCHEMBSE 524396
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthModerate
TechnicalsBearish
52-week range
−36.62% from high
₹29
₹26+14.73% from low₹46
Current
₹29.37
Prev close
₹30.26
Day
−2.94%
Price performance
1D
−3.04%
1W
−6.53%
1M
+1.03%
3M
−4.68%
6M
−7.00%
1Y
−25.21%
YTD
−12.30%

Financials

Revenue, profit & margin
P/E ratio
91.9×
BIOFILCHEM is 183% above the sector median of 32.5×
BIOFILCHEM91.9×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales17.375.0315.208.442.4114.208.356.4313.540.867.5712.351.67
YoY Sales growth+562.98%+237.58%+11.60%+247.33%-86.13%+182.31%-45.07%-23.82%+461.83%-93.94%-9.34%+92.07%-87.67%
Expenses17.134.8415.248.132.2913.898.246.4213.420.777.1412.211.57
Operating Profit0.240.19-0.040.310.120.310.110.010.120.090.430.140.10
OPM %1.38%3.78%-0.26%3.67%4.98%2.18%1.32%0.16%0.89%10.47%5.68%1.13%5.99%
Other Income0.030.030.410.030.020.020.242.830.060.080.110.060.13
Interest0.010.000.020.010.010.010.010.010.000.000.000.000.01
Depreciation0.110.110.080.100.100.100.080.070.070.070.070.070.07
Profit before tax0.150.110.270.230.030.220.262.760.110.100.470.130.15
Tax %20.00%18.18%11.11%26.09%33.33%27.27%23.08%12.68%27.27%30.00%55.32%23.08%26.67%
Net Profit0.120.090.250.170.020.160.202.410.080.080.210.110.12
EPS in Rs0.070.060.150.100.010.100.121.480.050.050.130.070.07
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +0.09% · closed higher next day 0 of last 1
 Q1FY27
Broadcast11 Aug '26◦
Earnings day+0.09%
+1 day−2.57%
+5 days−5.30%
+15 days−2.11%
+30 days−0.95%
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
46.79%Promoter
Promoters46.79%
FIIs0.00%
DIIs0.08%
Public53.13%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.764,52,2510.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.161,78,3740.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.531,23,9800.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.421,19,7000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.471,16,1190.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.811,14,3160.92%852−35.05%7,404−2.44%15.49%
Biofil Chemicals₹29.3791.88480.00%0+50.00%2−87.67%2.97%
Median: 160 Co.₹432.2032.471,9830.08%13+33.73%179+21.23%14.94%

Filings